In line with this, in an experimental mouse model of AIH, treatment with complexed IL-2/anti-IL-2 could increase the number of Foxp3+ TREG and diminish disease severity [16] (Fig. 1). This evidence concerns the gene FOXP3 and autoimmune hepatitis.